Search clinical trials for: De Novo coronary lesions

Total 489719 results

Second Affiliated Hospital, School of Medicine,...
Ningbo No. 1 Hospital

Unknown

FrActional Flow Reserve Guided Drug Coated Balloon Only Strategy in De Novo coronarY Lesions (FADDY) (FADDY)

Coronary Stenosis

China
The People's Hospital of Liaoning Province

Unknown

PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)

Stable Angina Pectoris | Unstable Angina Pectoris

China
Medtronic Vascular

Completed

RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries (RJ-SVS)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Heart Centre Rotenburg
B. Braun Melsungen AG; Clinical Research Institute Rotenburg a.d.F.

Completed

Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions (PEPCAD V)

Ischemia | Stenosis

Germany
C. R. Bard

Completed

De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions

Coronary Artery Stenosis

Netherlands
Tryton Medical, Inc.

Completed

Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries (TRYTON)

Coronary Atherosclerosis of Native Coronary Artery | Bifurcation Lesions: de Novo Lesions of the Main and Side Branch of Native Coronary Artery

United States
Yonsei University

Completed

Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

Multi-vessel Diseases, Angina

Korea, Republic of
Abbott Medical Devices

Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Thailand, Israel, Spain, Italy, United Kingdom, Malaysia, Austria, France, Germany, Poland
Biotronik AG

Completed

Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice (ENERGY)

De Novo and Re-stenosed Coronary Artery Lesions

Switzerland, Netherlands, Israel, Spain, Latvia, Germany, Austria, Belgium, France, Ireland
BIOrest Ltd.
Stanford University; Cardiovascular Research Foundation, New York; Baim Institute...

Completed

Biorest Liposomal Alendronate With Stenting sTudy (BLAST) (BLAST)

Coronary Artery Stenosis

Israel
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
Sahajanand Medical Technologies Pvt. Ltd.
CMS Medical

Completed

Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

Coronary Restenosis

Brazil
MINVASYS
European Cardiovascular Research Center

Completed

Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE) (DEBSIDE)

Coronary Disease

France
Sophie JACOB
Institut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaborators

Withdrawn

REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity) (REBECCA)

Breast Cancer | Toxicity Due to Radiotherapy | Lesion; Cardiac

France
CID S.p.A.

Unknown

Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions

Coronary Artery Disease

China
CID S.p.A.

Unknown

Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions

Coronary Artery Disease

China
Biotronik AG

Completed

First in Man Trial - BIOSOLVE-I (BIOSOLVE-I)

de Novo Lesions in Native Coronary Arteries

Netherlands, Switzerland, Germany, Belgium
Aalborg University Hospital
Aachen Resonance GmbH

Terminated

The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study (EXPEL)

Stable Angina | Coronary Stenosis

Denmark
Biotronik AG

Completed

First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions (BIOFLOW-I)

Coronary Artery Disease

Romania
S.M. Misericordia Hospital

Completed

Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo Lesions (DESERT)

Stable Coronary Artery Disease | Silent Myocardial Ischemia | In-stent(BMS)Restenosis | De-novo, Atherosclerotic, Coronary Lesions

Italy
Biotronik AG

Completed

BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions

Coronary Artery Disease

India
Sahajanand Medical Technologies Pvt. Ltd.

Terminated

Infinnium-Core™ Registry for the Treatment of Patients With De Novo Coronary Lesions

Coronary Artery Disease

India
Boston Scientific Corporation

Completed

A Study of the TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery Lesions

Coronary Artery Disease

United States, Singapore, New Zealand
Boston Scientific Corporation

Completed

A Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small Vessels

Coronary Artery Disease

United States, Singapore, New Zealand
Boston Scientific Corporation

Completed

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

Coronary Artery Disease

Canada, United States, Australia, Singapore, Taiwan, New Zealand, China
Boston Scientific Corporation

Completed

Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

Coronary Artery Disease

United States, Singapore, New Zealand, Taiwan
Boston Scientific Corporation

Completed

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions

Coronary Stenosis

United States
Cordis Corporation

Completed

A Study of the Presillion Stent in de Novo Coronary Lesions (PRESILLION)

Coronary Artery Disease

Belgium
Cordis Corporation

Completed

NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions

Coronary Artery Disease

United States
Catholic University of the Sacred Heart

Unknown

Intimal Hyperplasia Evaluated by Optical Coherence Tomography (OCT) in de Novo Coronary Lesions Treated by Drug-eluting Balloon and Bare-metal Stent (IN-PACT CORO)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions (SCORPIUS)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

Coronary Artery Disease

United States
Medlogics Device Corporation
Stanford University; Baim Institute for Clinical Research

Unknown

Cobra II Study: Use of the Cobra™ Cobalt Super Alloy Coronary Stent System in the Treatment of Coronary Artery Disease

Coronary Artery Disease

Israel, United Kingdom, Netherlands, Germany
Cordis Corporation

Completed

The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions. (E-SIRIUS)

Coronary Artery Disease

Germany
International Biomedical Systems S.p.A.

Unknown

Assessment of the Numen Stent With Evaluation in a Randomized Study (ANSWERS)

Lesion

France
JW Medical Systems Ltd

Unknown

A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions (EVOLUTION)

Myocardial Infarction | Ischemia | Cardiac Death

China
Cordis Corporation

Completed

The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions. (C-SIRIUS)

Coronary Artery Disease
Boston Scientific Corporation

Completed

TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program (ARRIVE 2)

Cardiovascular Disease | de Novo Coronary Lesions

United States
Cordis Corporation

Completed

The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions. (SVELTE)

Coronary Artery Disease

Switzerland
National University Hospital, Singapore
Boston Scientific Corporation

Unknown

A Prospective Evaluation in a Randomized Trial of TAXUS in the Treatment of De Novo Coronary Artey Lesions

Coronary Heart Disease
Cordis Corporation

Completed

Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)

Coronary Artery Disease

Brazil
pablo Juan-Salvadores
Fundacin Biomedica Galicia Sur; Conselleria de Saúde Pública de Galicia; Conselleria...

Recruiting

Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease (AIRHEART)

Myocardial Infarction | Angina, Stable | Acute Coronary Syndrome | MINOCA | Coronary Artery Disease Premature

Spain
MetaOptima Technology Inc.

Not yet recruiting

Multi-Center Study to Evaluate the Performance of DermDx for Primary Care Physicians in the Detection of Skin Cancers

Skin Cancer
Saint-Joseph University

Recruiting

Minimal Instrumentation With Intracanal Heating and Activation of Sodium Hypochlorite for the Management of Teeth With Periapical Lesions

Heating and Activation of Sodium Hypochlorite

Lebanon
Consorci Sanitari de l'Alt Penedès i Garraf

Recruiting

Adherence to Secondary Prevention Guidelines for Cardiovascular Risk

Peripheral Arterial Disease | Atherosclerosis | Acute Coronary Syndrome | Ischemic Heart Disease | Stroke, Ischemic

Spain
Yinyi(Liaoning) Biotech Co., Ltd.

Not yet recruiting

Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions

Coronary Artery Disease
Medical University of Lublin

Recruiting

Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis

Mastocytosis | Bones

Poland
Ohio State University Comprehensive Cancer Center

Not yet recruiting

A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients

Low Anterior Resection Syndrome | Rectal Carcinoma

United States

3

Subscribe